Publications by authors named "Toru Narusaka"

Claim this Profile
O
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody.
Noriyuki Nishiwaki, Kazuhiro Noma, Toshiaki Ohara, Tomoyoshi Kunitomo, Kento Kawasaki, Toru Narusaka

Cancer Immunol Immunother· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conventional Cancer Therapies Can Accelerate Malignant Potential of Cancer Cells by Activating Cancer-Associated Fibroblasts in Esophageal Cancer Models.
Satoshi Komoto, Kazuhiro Noma, Takuya Kato, Teruki Kobayashi, Noriyuki Nishiwaki, Toru Narusaka

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-targeted near-infrared photoimmunotherapy for esophageal cancer and cancer-associated fibroblasts in the tumor microenvironment.
Hiroaki Sato, Kazuhiro Noma, Toshiaki Ohara, Kento Kawasaki, Masaaki Akai, Toru Narusaka

Sci Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-reactive protein to albumin ratio predicts difficult laparoscopic cholecystectomy in patients with acute cholecystitis diagnosed according to the Tokyo Guidelines 2018.
Masashi Utsumi, Yuya Sakurai, Toru Narusaka, Naoyuki Tokunaga, Koji Kitada

Asian J Endosc Surg· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative Albumin-to-Globulin Ratio Predicts Prognosis in Hepatocellular Carcinoma: A Cohort Study Including Non-Hepatitis Virus-Infected Patients.
Masashi Utsumi, Koji Kitada, Naoyuki Tokunaga, Toru Narusaka, Ryosuke Hamano

Dig Surg· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combined prediction model for biliary tract cancer using the prognostic nutritional index and pathological findings: a single-center retrospective study.
Masashi Utsumi, Koji Kitada, Naoyuki Tokunaga, Takamitsu Kato, Toru Narusaka

BMC Gastroenterol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanog is a promising chemoresistant stemness marker and therapeutic target by iron chelators for esophageal cancer.
Toru Narusaka, Toshiaki Ohara, Kazuhiro Noma, Noriyuki Nishiwaki, Yuki Katsura

Int J Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.
Masashi Utsumi, Koji Kitada, Naoyuki Tokunaga, Yusuke Yoshida, Toru Narusaka

Anticancer Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Combination Cancer Therapy with Iron Chelator Targeting Cancer Stem Cells via Suppressing Stemness.
Yuki Katsura, Toshiaki Ohara, Kazuhiro Noma, Takayuki Ninomiya, Hajime Kashima, Toru Narusaka

Cancers (Basel)· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A case of metastatic carcinoma of the colon after curative resection for gastric cancer].
Megumi Watanabe, Toru Narusaka, Dofu Hayashi, Toshihisa Matsumura, Yasuyuki Nonaka

Gan To Kagaku Ryoho· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis